1877.HK - Shanghai Junshi Biosciences Co., Ltd.

HKSE - HKSE Delayed price. Currency in HKD
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in CNY. All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
2,856,442
1,453,493
4,024,841
1,594,897
775,089
Cost of revenue
1,114,717
526,282
1,258,187
372,531
90,684
Gross profit
1,741,725
927,211
2,766,654
1,222,366
684,405
Operating expenses
Research development
2,183,702
2,384,373
2,068,739
1,778,023
946,100
Selling general and administrative
1,267,061
1,293,973
1,382,513
1,131,317
564,285
Total operating expenses
3,376,727
3,644,157
3,359,361
2,890,784
1,478,839
Operating income or loss
-1,635,002
-2,716,946
-592,707
-1,668,418
-794,434
Interest expense
12,979
29,370
21,833
29,391
13,300
Income before tax
-1,680,885
-2,675,202
-592,648
-1,669,461
-763,124
Income tax expense
56,189
-93,107
135,533
-3,822
-18,891
Income from continuing operations
-1,737,074
-2,582,095
-728,181
-1,665,639
-744,233
Net income
-1,640,420
-2,386,067
-718,557
-1,665,639
-743,922
Net income available to common shareholders
-1,640,420
-2,386,067
-718,557
-1,665,639
-743,922
Basic EPS
-
-
-0.80
-2.02
-0.95
Diluted EPS
-
-
-0.80
-2.02
-0.95
Basic average shares
-
-
892,660
824,817
783,624
Diluted average shares
-
-
892,660
824,817
783,624
EBITDA
-
-2,352,178
-308,256
-1,488,708
-690,233